Focus: Erbe is a German-headquartered surgical systems company founded in 1851, specializing in minimally invasive surgical technologies including argon plasma coagulation, cryotherapy, and electrosurgical devices. The company operates across multiple therapeutic areas including oncology, gastroenterology, and women's health.
Profile data last refreshed 5h ago · AI intelligence enriched 2mo ago
Stable — net +2 jobs in 30d
6 added, 4 removed. Backfill posture.
Erbe represents a stable, established medical device player with broad clinical reach, but limited hiring activity and minimal visa sponsorship suggest cautious workforce expansion rather than growth-phase opportunity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Proprietary surgical system for women's health with active clinical validation.
Help build intelligence for Erbe
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Erbe's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Advanced thermal ablation platform expanding oncology footprint with ongoing trials.
Cryosurgical platform with FDA clearance (K190651) and multiple indication expansions.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo